Discovery and structure-activity relationship of 3-methoxy-N-(3-(1-methyl-1 H-pyrazol-5-yl)-4-(2-morpholinoethoxy)phenyl)benzamide (APD791): A highly selective 5-hydroxytryptamine_(2A) receptor inverse agonist for the treatment of arterial thrombosis
作者:
发布时间
2013-11-20
- 浏览4

Journal of Medicinal Chemistry
4412-4421页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文